Poll: 1 in 5 US adults report trouble affording prescription drugs

Poll: 1 in 5 US adults report trouble affording prescription drugs
© istock

About 1 in 5 U.S. adults say that they or someone in their household has been unable to afford drugs that were prescribed to them in the past 12 months, according to a new poll from Gallup and West Health. 

The survey found that 22.9 percent of U.S. adults said there had been a time in the past year when their household was unable to pay for drugs they were prescribed, up from 18.9 percent in January. 

ADVERTISEMENT

The poll illustrates the struggles many Americans have paying for medication at a time when lowering drug prices is an intense subject of debate in Washington. 

President TrumpDonald John TrumpCNN's Don Lemon explains handling of segment after Trump criticism NPR reporter after Pompeo clash: Journalists don't interview government officials to score 'political points' Lawyer says Parnas can't attend Senate trial due to ankle bracelet MORE has railed against high drug prices and has proposed some steps, including linking certain Medicare drug prices to lower ones paid in other countries, but he has not taken any major action that has gone into effect yet. 

The Gallup survey finds the public is mostly negative on Trump’s performance on the issue so far, with 66 percent of adults saying he has done “not very much” or “none at all” to fight high drug prices. Twenty percent said he had done a “fair amount” and 7 percent said “a great deal.”

Speaker Nancy PelosiNancy PelosiDemocrats offer mixed reactions to Trump's Mideast peace plan James Taylor to perform at awards ceremony for Ruth Bader Ginsburg this week Trump offers two-state peace plan for Israeli-Palestinian conflict amid skepticism MORE (D-Calif.) is pushing a sweeping bill to allow the secretary of Health and Human Services to negotiate lower prices on up to 250 drugs per year. Republicans oppose that measure, warning it would hinder the development of new treatments, but some are supporting smaller measures like a bill in the Senate from Sens. Chuck GrassleyCharles (Chuck) Ernest GrassleyOvernight Energy: Democrats unveil draft climate bill | Plan aims for carbon neutrality by 2050 | GOP senators press IRS on electric vehicle tax credit GOP senator: John Bolton should go public with what he knows GOP senators press IRS on enforcement of electric vehicle tax credit MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenTax season could bring more refund confusion Hillicon Valley — Presented by Philip Morris International — Wyden asks NSA to investigate White House cybersecurity | Commerce withdraws Huawei rule after Pentagon objects | Warren calls on Brazil to drop Greenwald charges Wyden vows push to force release of Khashoggi assessment MORE (D-Ore.). 

Drug companies say that the problem is insurers and pharmacy benefit managers who are not passing discounts they receive on to consumers.